A1BG | Alpha-1-B glycoprotein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
A1CF | APOBEC1 complementation factor | | | | | | Tissue enhanced |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AADAC | Arylacetamide deacetylase | Enzymes
| | | | | Tissue enhanced |
AADACL2 | Arylacetamide deacetylase-like 2 | Predicted secreted proteins
| | | | | Tissue enriched |
AADACL3 | Arylacetamide deacetylase-like 3 | | | | | | Group enriched |
AADAT | Aminoadipate aminotransferase | Enzymes Mitochondrial proteins
| | | | | Tissue enhanced |
AANAT | Aralkylamine N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
AARD | Alanine and arginine rich domain containing protein | | | | | | Tissue enriched |
AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ABCA10 | ATP-binding cassette, sub-family A (ABC1), member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA12 | ATP-binding cassette, sub-family A (ABC1), member 12 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCA13 | ATP-binding cassette, sub-family A (ABC1), member 13 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC12 | ATP-binding cassette, sub-family C (CFTR/MRP), member 12 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
ABCG4 | ATP-binding cassette, sub-family G (WHITE), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABHD1 | Abhydrolase domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ABHD12B | Abhydrolase domain containing 12B | | | | | | Tissue enriched |
ABI3 | ABI family, member 3 | | | | | | Tissue enhanced |
ABLIM2 | Actin binding LIM protein family, member 2 | | | | | | Tissue enhanced |
ABLIM3 | Actin binding LIM protein family, member 3 | Plasma proteins
| | | | | Tissue enhanced |
ABRA | Actin-binding Rho activating protein | | | | | | Group enriched |
AC002365.1 | Homo sapiens uncharacterized LOC100288814 (LOC100288814), mRNA. | Predicted membrane proteins
| | | | | Tissue enriched |
AC002472.13 | Leucine-rich repeat-containing protein LOC400891 | | | | | | Tissue enhanced |
AC003102.1 | | | | | | | Tissue enriched |
AC004017.1 | Uncharacterized protein | | | | | | Tissue enhanced |
AC004381.6 | Putative RNA exonuclease NEF-sp | | | | | | Tissue enriched |
AC005008.2 | Uncharacterized protein | | | | | | Tissue enriched |
AC005082.1 | Uncharacterized protein | | | | | | Tissue enriched |
AC005358.1 | | | | | | | Tissue enriched |
AC005481.5 | Uncharacterized protein | | | | | | Tissue enhanced |